Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Disposition | 2024-04-05 4:05 pm | N/A 2024-04-05 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Chief Executive Officer 10% Owner | 1,165,048 | $0 | 19,627,346 (Direct) | View |
| 2024-04-03 Option Award | 2024-04-05 4:05 pm | N/A 2025-04-05 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Chief Executive Officer 10% Owner | 1,165,048 | $0 | 19,627,346 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:05 pm | N/A 2024-04-05 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z Vice Chairman Director | 129,450 | $0 | 5,831,271 (Direct) | View |
| 2024-04-03 Option Award | 2024-04-05 4:05 pm | N/A 2025-04-05 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z Vice Chairman Director | 129,450 | $0 | 5,831,271 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-18 4:06 pm | N/A 2034-03-12 | Citius Pharmaceuticals Inc. | CTXR | Smith Robert Joseph Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Webb Carol Director | 75,000 | $0 | 400,405 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Czuczman Myron Chief Medical Officer | 300,000 | $0 | 1,400,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z Vice Chairman Director | 400,000 | $0 | 5,831,271 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Holuka Eugene Myron Director | 75,000 | $0 | 390,749 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | MCGRATH DENNIS M Director | 75,000 | $0 | 150,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Dutia Suren G Director | 75,000 | $0 | 401,667 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Bartushak Jaime Chief Financial Officer | 300,000 | $0 | 1,428,620 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-12 4:15 pm | N/A 2033-10-10 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Chief Executive Officer 10% Owner | 550,000 | $0 | 19,627,346 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:06 pm | N/A 2033-02-07 | Citius Pharmaceuticals Inc. | CTXR | MCGRATH DENNIS M Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:10 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Kane William Director | 75,000 | $0 | 325,405 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:09 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Dutia Suren G Director | 75,000 | $0 | 326,667 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:08 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z Vice Chairman Director | 400,000 | $0 | 5,431,271 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:08 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Executive Chairman 10% Owner | 550,000 | $0 | 20,233,803 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:07 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Bartushak Jaime Chief Financial Officer | 300,000 | $0 | 1,128,620 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:07 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | SAFIR HOWARD Director | 75,000 | $0 | 325,405 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:06 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Holuka Eugene Myron Director | 75,000 | $0 | 315,749 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:06 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Webb Carol Director | 75,000 | $0 | 325,405 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:05 pm | N/A 2032-10-04 | Citius Pharmaceuticals Inc. | CTXR | Czuczman Myron Chief Medical Officer | 300,000 | $0 | 1,100,000 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z President and CEO | 665,000 | $0 | 5,031,271 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Executive Chairman 10% Owner | 650,000 | $0 | 19,683,803 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Webb Carol Director | 75,000 | $0 | 250,405 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Bartushak Jaime Chief Financial Officer | 300,000 | $0 | 828,620 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | SAFIR HOWARD Director | 75,000 | $0 | 250,405 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Holuka Eugene Myron Director | 75,000 | $0 | 240,749 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Dutia Suren G Director | 75,000 | $0 | 251,667 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Czuczman Myron Chief Medical Officer | 300,000 | $0 | 800,000 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 5:25 pm | N/A 2031-10-11 | Citius Pharmaceuticals Inc. | CTXR | Kane William Director | 75,000 | $0 | 250,405 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:03 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | Kane William Director | 15,000 | $0 | 175,405 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:03 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | Dutia Suren G Director | 15,000 | $0 | 176,667 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:02 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | HOLUBIAK MYRON Z President and CEO 10% Owner | 310,000 | $0 | 4,366,271 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:02 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | Mazur Leonard L Executive Chairman 10% Owner | 300,000 | $0 | 19,033,803 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:01 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | Bartushak Jaime Chief Financial Officer | 100,000 | $0 | 528,620 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:01 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | SAFIR HOWARD Director | 15,000 | $0 | 175,405 (Direct) | View |
| 2021-07-22 Option Award | 2021-07-26 5:01 pm | N/A 2031-07-22 | Citius Pharmaceuticals Inc. | CTXR | Holuka Eugene Myron Director | 15,000 | $0 | 165,749 (Direct) | View |